Evotec SE (EVO)
NASDAQ: EVO · IEX Real-Time Price · USD
4.950
+0.090 (1.85%)
At close: Jul 2, 2024, 4:00 PM
4.980
+0.030 (0.61%)
After-hours: Jul 2, 2024, 6:34 PM EDT

Evotec SE Revenue

Revenue in the quarter ending September 30, 2023 was $208.81M with 15.19% year-over-year growth. In the year 2022, Evotec SE had annual revenue of $799.41M with 13.83% growth.

Revenue (ttm)
$799.41M
Revenue Growth
+13.83%
P/S Ratio
n/a
Revenue / Employee
$161,432
Employees
4,952
Market Cap
1.76B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022799.41M97.10M13.83%
Dec 31, 2021702.31M91.43M14.97%
Dec 31, 2020610.88M109.27M21.78%
Dec 31, 2019501.61M440.41M719.61%
Dec 31, 200961.20M6.00M10.86%
Dec 31, 200855.21M7.14M14.85%
Dec 31, 200748.07M-5.32M-9.96%
Dec 31, 200653.39M3.96M8.00%
Dec 31, 200549.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.62B
National HealthCare 1.17B
Harmony Biosciences Holdings 617.51M
Veracyte 375.47M
Zai Lab 291.07M
Immunocore Holdings 264.25M
Recursion Pharmaceuticals 46.24M
Revenue Rankings